Related Experiment Videos
Acute electroretinographic changes during sildenafil (Viagra) treatment for erectile dysfunction
Corrado Balacco Gabrieli1, Federico Regine, Enzo M Vingolo
1Department of Ophthalmology, University of Rome La Sapienza, Rome, Italy. corrado.balacco@uniroma1.it
Documenta Ophthalmologica. Advances in Ophthalmology
|December 10, 2003
Summary
Sildenafil (Viagra) significantly improved rod vision sensitivity in 12 subjects. The drug increased Vmax, indicating a stronger rod response to light, and decreased K, showing enhanced light sensitivity.
Area of Science:
- Ophthalmology
- Pharmacology
- Neuroscience
Background:
- Sildenafil, commonly known as Viagra, is a medication primarily used for erectile dysfunction.
- Its effects on visual function, particularly scotopic (low-light) vision, are of interest.
- The Naka-Rushton equation is a mathematical model used to describe visual sensory adaptation.
Purpose of the Study:
- To investigate the impact of sildenafil on scotopic electroretinogram (ERG) b-wave function.
- To quantify changes in rod visual sensitivity following sildenafil administration.
Main Methods:
- Twelve healthy subjects received a 50 mg dose of sildenafil.
- Scotopic ERG measurements were performed before and one hour after sildenafil ingestion.
- The Naka-Rushton equation was applied to analyze the b-wave luminance-response function.
Main Results:
- Sildenafil significantly altered key parameters of the scotopic ERG b-wave function.
- A statistically significant increase in Vmax was observed, indicating enhanced rod response to light.
- A statistically significant decrease in K was noted, signifying increased rod sensitivity to light stimuli.
Conclusions:
- Sildenafil (Viagra) administration demonstrably enhances rod-mediated visual sensitivity.
- The observed increases in Vmax and decreases in K suggest a positive effect on low-light vision.
- These findings warrant further investigation into sildenafil's potential therapeutic applications in visual disorders.